Building Competency in Diabetes Education THE ESSENTIALS

BASAL-BOLUS INSULIN THERAPY | 12-35 Given the similar pharmacokinetics of the rapid-acting insulins, the actual choice of a specific insulin may depend more on the insulin delivery device and its suitability for the patient. Faster-acting insulin aspart has not yet been approved for use in CSII in Canada at time of writing.